Related Experiment Video

Updated: May 18, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Management of congenital adrenal hyperplasia in childhood

Mimi S Kim1, Anna Ryabets-Lienhard, Mitchell E Geffner

  • 1Center for Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles, Los Angeles, California 90027, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|October 6, 2012
PubMed

Insights

Recent advances in congenital adrenal hyperplasia (CAH) management focus on new medication delivery and genetic insights for pediatric patients. Optimal treatment strategies, from prenatal care to adulthood, are continuously evolving, requiring further research.

Area of Science:

  • Pediatric Endocrinology
  • Genetics
  • Pharmacology

Background:

  • Congenital adrenal hyperplasia (CAH) presents ongoing management challenges in pediatric care.
  • Glucocorticoid replacement is the primary treatment, with ongoing research into novel formulations and delivery methods.
  • Optimal treatment strategies for CAH span prenatal stages through adulthood.

Purpose of the Study:

  • To review recent advancements in the management of pediatric patients with congenital adrenal hyperplasia (CAH).
  • To highlight new findings in medication regimens, delivery mechanisms, and the role of genetics in CAH care.
  • To identify areas requiring further research in optimizing CAH treatment.

Main Methods:

  • Review of recent studies on medication regimens, including prenatal dexamethasone.
  • Analysis of research on medication delivery systems and hormonal control monitoring.
  • Examination of the role of genotyping and genetics in pediatric CAH management.

Main Results:

  • Recent studies explore optimal medication regimens and prenatal dexamethasone treatment for CAH.
  • Advances include new medication delivery methods and improved monitoring of hormonal control.
  • The role of genotyping and genetics in managing children with CAH is increasingly recognized.

Conclusions:

  • Optimal management of pediatric CAH requires further investigation, particularly regarding fludrocortisone replacement and monitoring frequency.
  • Areas needing more research include catecholamine status, stress-dosing protocols, and early screening for complications.
  • Further randomized and prospective studies are essential to refine CAH treatment guidelines.
Abstract

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...